Brief: Pharmasimple H1 Revenue Up At 30.2 Million Euros
July 21 (Reuters) - PHARMASIMPLE SA ALPHS.PA :
* H1 REVENUE EUR 30.2 MILLION VERSUS EUR 14.3 MILLION YEAR
AGO
* PLANS FOR H2 TO CONTINUE GOOD ORIENTATION OF ACTIVITY WITH
AN
INCREASE IN INTERNET ORDERS AND MAINTAINING A POSITIVE DYNAMIC
AROUND PRODUCTS B2B
* CONFIRMS EXPECTATION OF POSITIVE EBITDA FOR H1 2020
(VERSUS.
NEGATIVE IN 2019)
Source text for Eikon: ID:nACT64363
Further company coverage: ALPHS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Pharmasimple SA
See all newsBrief: Pharmasimple Says It Received Order To Suspend Stock Consolidation
Brief: Pharmasimple Says Stock Consolidation Approved
Brief: Pharmasimple H1 EBITDA Loss Widens To 3.6 Million Euros
Brief: Pharmasimple Announces Reverse Stock Split
Brief: Pharmasimple: Suspension Of OCA Drawdowns From Oct For At Least 6 Months